Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on November 15, 2019, 10:59:17 am
-
As the U.S. population living with hepatitis C virus (HCV) ages, the safety and efficacy of direct-acting antiviral (DAA) treatment for the senior population is an important concern. The bulk of those living with HCV in the United States are baby boomers—those born between 1945 and 1965—about half of whom are over age 65 and the eldest of whom are just shy of 75 years old.
Research has indicated that hep C–related cirrhosis, which is severe scarring of the liver, will have a particular impact on those older than 60.
Now a group of German researchers has conducted the first systematic review and meta-analysis of available medical literature to assess the relative effects of interferon-free DAA regimens on seniors and their younger counterparts.
Read more...
https://www.hepmag.com/article/hepatitis-c-treatments-safe-effective-seniors